Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

What is new in movement disorders?

W Poewe1

  • 1Department of Neurology, University of Innsbruck, Austria. werner.poewe@uibk.ac.at

Wiener Klinische Wochenschrift
|October 20, 1999
PubMed
Summary

Movement disorders involve deficits in voluntary motor function, often linked to the cortico-basal ganglia circuits. Recent discoveries highlight pathological protein aggregation as a common factor in neurodegenerative movement disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional connectivity and topology in patients with restless legs syndrome: a case-control resting-state functional magnetic resonance imaging study.

European journal of neurology·2020
Same author

Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions.

European journal of neurology·2019
Same author

Burden of non-motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa-carbidopa intestinal gel.

European journal of neurology·2018
Same author

Quality of life improvements in patients with cervical dystonia following treatment with a liquid formulation of abobotulinumtoxinA (Dysport<sup>®</sup> ).

European journal of neurology·2018
Same author

The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature.

European journal of neurology·2018
Same author

Response to: On the role of visual electrophysiology in parkinson's disease.

Parkinsonism & related disorders·2017

Area of Science:

  • Neurology
  • Neuroscience
  • Genetics

Background:

  • Movement disorders encompass a diverse range of conditions characterized by impaired voluntary motor function.
  • In clinical settings, these disorders are typically associated with pathologies affecting the cortico-basal ganglia circuits.
  • Recent advancements have significantly improved our understanding of the causes and mechanisms underlying movement disorders.

Purpose of the Study:

  • To explore the etiological and pathophysiological factors of movement disorders.
  • To investigate the role of new gene mutations in the molecular pathogenesis of neurodegenerative movement disorders.
  • To identify common pathogenic links, such as protein aggregation, across various movement disorders.

Main Methods:

  • Review of recent scientific literature on movement disorders.
  • Analysis of genetic discoveries related to movement disorder pathogenesis.
  • Examination of the role of protein aggregation in neurodegeneration.

Main Results:

  • New gene mutations are providing deeper insights into the molecular basis of movement disorders.
  • Pathological protein aggregation is emerging as a unifying factor in the neurodegeneration seen in conditions like Parkinson's disease, dystonia, and spinocerebellar ataxia.
  • Despite advances in understanding, new symptomatic or preventive therapies have not yet been developed.

Conclusions:

  • Understanding the molecular pathogenesis of movement disorders is rapidly advancing.
  • Protein aggregation is a significant common pathway in neurodegenerative movement disorders.
  • Symptomatic treatment, particularly for Parkinson's disease, remains a vital and innovative area of neurological therapy.

Related Experiment Videos